Income Statement
Balance Sheet
Cash Flow
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 8,317 | 8,313 | 5,113 | 8,016 |
| Gross Profit | -8,317 | -8,313 | -5,113 | -8,016 |
| Selling General And Administration | 86,033 | 98,192 | 158,903 | 115,248 |
| General And Administrative Expense | 86,014 | 95,171 | 103,350 | 115,093 |
| Other Operating Expenses | 82,543 | 11,518 | 20,352 | 53,360 |
| Operating Expense | 168,576 | 109,710 | 179,255 | 168,608 |
| Operating Income | -176,893 | -118,023 | -184,368 | -176,624 |
| EBIT | -168,404 | -120,068 | -311,426 | -157,043 |
| Interest Expense | 3,178 | 6,844 | 19,129 | 11,136 |
| Interest Expense Non Operating | 3,178 | 6,844 | 19,129 | 11,136 |
| Net Interest Income | -3,178 | -6,844 | -19,129 | -11,136 |
| Other Income Expense | 8,489 | -2,045 | -127,058 | 19,581 |
| Special Income Charges | -- | 0.00 | -- | -- |
| Gain On Sale Of Security | 8,489 | -2,045 | -32,820 | 19,581 |
| Pretax Income | -171,582 | -126,912 | -330,555 | -168,179 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -171,582 | -118,599 | -287,559 | -168,179 |
| Net Income From Continuing Operation Net Minority Interest | -171,582 | -118,599 | -287,559 | -168,179 |
| Net Income Including Noncontrolling Interests | -171,582 | -126,912 | -330,555 | -168,179 |
| Net Income Common Stockholders | -171,582 | -118,599 | -287,559 | -168,179 |
| Net Income | -171,582 | -118,599 | -287,559 | -168,179 |
| EBITDA | -160,087 | -111,755 | -306,313 | -149,027 |
| Normalized EBITDA | -168,576 | -109,710 | -179,255 | -168,608 |
| Reconciled Depreciation | 8,317 | 8,313 | 5,113 | 8,016 |
| Basic EPS | -0.01 | -0.01 | -- | -0.02 |
| Diluted EPS | -0.01 | -0.01 | -- | -0.02 |
| Basic Average Shares | 18.4M | 15.2M | -- | 6.3M |
| Diluted Average Shares | 18.4M | 15.2M | -- | 6.3M |
| Total Unusual Items | 8,489 | -2,045 | -127,058 | 19,581 |
| Total Unusual Items Excluding Goodwill | 8,489 | -2,045 | -127,058 | 19,581 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -180,071 | -116,554 | -160,501 | -187,760 |
| Diluted NI Availto Com Stockholders | -171,582 | -118,599 | -287,559 | -168,179 |
| Impairment Of Capital Assets | -- | 0.00 | -- | -- |
| Net Income Continuous Operations | -171,582 | -126,912 | -330,555 | -168,179 |
| Net Non Operating Interest Income Expense | -3,178 | -6,844 | -19,129 | -11,136 |
| Other Gand A | 86,014 | 95,171 | 103,350 | 115,093 |
| Reconciled Cost Of Revenue | 8,317 | 8,313 | 5,113 | 8,016 |
| Selling And Marketing Expense | 19.00 | 3,021 | 55,553 | 155.00 |
| Total Expenses | 176,893 | 118,023 | 184,368 | 176,624 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 6,992 | 10,329 | 79,080 | 714.00 |
| Cash Cash Equivalents And Short Term Investments | 6,992 | 10,329 | 79,080 | 714.00 |
| Cash Financial | 6,992 | 10,329 | 79,080 | 714.00 |
| Receivables | 9,495 | 3,527 | 2,625 | 2,501 |
| Prepaid Assets | 4,276 | 4,484 | 4,308 | 4,275 |
| Current Assets | 20,763 | 18,340 | 86,013 | 7,490 |
| Gross PPE | 272,427 | 279,673 | 284,821 | 471,572 |
| Net PPE | 272,427 | 279,673 | 284,821 | 471,572 |
| Total Non Current Assets | 272,427 | 279,673 | 284,821 | 471,572 |
| Total Assets | 293,190 | 298,013 | 370,834 | 479,062 |
| Current Debt | 66,067 | 65,518 | 64,969 | 130,490 |
| Current Debt And Capital Lease Obligation | 105,558 | 105,470 | 101,985 | 165,908 |
| Accounts Payable | 483,569 | 117,992 | 109,995 | 639,553 |
| Payables | 621,869 | 221,792 | 893,318 | 1.1M |
| Payables And Accrued Expenses | 621,869 | 221,792 | 893,318 | 1.1M |
| Current Liabilities | 727,427 | 327,262 | 995,303 | 1.2M |
| Long Term Debt | 65,000 | 65,000 | 65,000 | -- |
| Long Term Debt And Capital Lease Obligation | 86,794 | 98,787 | 107,707 | 52,013 |
| Long Term Capital Lease Obligation | 21,794 | 33,787 | 42,707 | 52,013 |
| Other Non Current Liabilities | -- | 313,100 | 313,100 | -- |
| Total Non Current Liabilities Net Minority Interest | 86,794 | 411,887 | 420,807 | 52,013 |
| Total Liabilities Net Minority Interest | 814,221 | 739,149 | 1.4M | 1.3M |
| Common Stock | 7.9M | 7.9M | 7.0M | 6.1M |
| Capital Stock | 7.9M | 7.9M | 7.0M | 6.1M |
| Retained Earnings | -8.9M | -8.7M | -8.6M | -8.3M |
| Common Stock Equity | -700,340 | -620,445 | -1.2M | -1.0M |
| Stockholders Equity | -700,340 | -620,445 | -1.2M | -1.0M |
| Total Equity Gross Minority Interest | -521,031 | -441,136 | -1.0M | -799,640 |
| Minority Interest | 179,309 | 179,309 | 179,309 | 222,305 |
| Total Capitalization | -635,340 | -555,445 | -1.2M | -1.0M |
| Net Tangible Assets | -700,340 | -620,445 | -1.2M | -1.0M |
| Tangible Book Value | -700,340 | -620,445 | -1.2M | -1.0M |
| Working Capital | -706,664 | -308,922 | -909,290 | -1.2M |
| Invested Capital | -569,273 | -489,927 | -1.1M | -891,455 |
| Total Debt | 192,352 | 204,257 | 209,692 | 217,921 |
| Net Debt | 124,075 | 120,189 | 50,889 | 129,776 |
| Share Issued | 18.4M | 18.4M | 12.4M | 6.3M |
| Ordinary Shares Number | 18.4M | 18.4M | 12.4M | 6.3M |
| Capital Lease Obligations | 61,285 | 73,739 | 79,723 | 87,431 |
| Current Capital Lease Obligation | 39,491 | 39,952 | 37,016 | 35,418 |
| Dueto Related Parties Current | 138,300 | 103,800 | 783,323 | 421,228 |
| Leases | 43,476 | 50,722 | 57,968 | -- |
| Other Current Borrowings | 66,067 | 65,518 | 64,969 | 130,490 |
| Other Equity Interest | 289,940 | 189,940 | 340,568 | 1.1M |
| Other Properties | 228,951 | 228,951 | 226,853 | 471,572 |
| Properties | 0.00 | 0.00 | 0.00 | -- |
| Taxes Receivable | 9,495 | 3,527 | 2,625 | 2,501 |
| Line Item | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|
| Operating Cash Flow | -91,344 | -69,511 | -7,030 | -61,046 |
| Cash Flow From Continuing Operating Activities | -91,344 | -69,511 | -7,030 | -61,096 |
| Depreciation And Amortization | 8,317 | 8,313 | 5,113 | 8,016 |
| Depreciation Amortization Depletion | 8,317 | 8,313 | 5,113 | 8,016 |
| Change In Working Capital | 84,306 | 38,357 | 197,582 | 96,115 |
| Changes In Account Receivables | -- | -- | -- | -19.00 |
| Change In Receivables | -5,936 | -902.00 | -12,057 | -2,520 |
| Change In Payables And Accrued Expense | 90,066 | 39,435 | 197,739 | 98,635 |
| Other Non Cash Items | 2,281 | 2,509 | -- | -- |
| Capital Expenditure | -- | -2,098 | -- | -- |
| Purchase Of PPE | -- | -2,098 | -- | -- |
| Net PPE Purchase And Sale | -- | -2,098 | 22,169 | -- |
| Investing Cash Flow | 0.00 | -2,098 | 22,169 | 40,000 |
| Cash Flow From Continuing Investing Activities | 0.00 | -2,098 | 22,169 | 40,000 |
| Issuance Of Debt | -- | -- | 0.00 | -- |
| Repayment Of Debt | -11,993 | -8,920 | -21,692 | -39,077 |
| Net Issuance Payments Of Debt | -11,993 | -8,920 | -21,692 | 64,723 |
| Issuance Of Capital Stock | 0.00 | 40,372 | 0.00 | 0.00 |
| Net Common Stock Issuance | 0.00 | 40,372 | 0.00 | 0.00 |
| Financing Cash Flow | 88,007 | 2,858 | 63,227 | 6,923 |
| Cash Flow From Continuing Financing Activities | 88,007 | 2,858 | 63,227 | 6,923 |
| Changes In Cash | -3,337 | -68,751 | 78,366 | -14,133 |
| Beginning Cash Position | 10,329 | 79,080 | 714.00 | 14,837 |
| End Cash Position | 6,992 | 10,329 | 79,080 | 714.00 |
| Free Cash Flow | -89,246 | -71,609 | -7,030 | -61,046 |
| Change In Prepaid Assets | -- | -176.00 | -- | -- |
| Common Stock Issuance | 0.00 | 40,372 | 0.00 | 0.00 |
| Depreciation | 8,317 | 8,313 | 5,113 | 8,016 |
| Long Term Debt Issuance | -- | -- | 0.00 | -- |
| Long Term Debt Payments | -11,993 | -8,920 | -21,692 | -39,077 |
| Net Foreign Currency Exchange Gain Loss | -6,353 | -91.00 | 9,201 | 2,952 |
| Net Income From Continuing Operations | -179,895 | -118,599 | -330,555 | -168,179 |
| Net Long Term Debt Issuance | -11,993 | -8,920 | -21,692 | 64,723 |
| Net Other Financing Charges | 100,000 | -28,594 | 84,919 | -57,800 |
| Operating Gains Losses | -6,353 | -91.00 | -42,901 | 2,952 |
| Sale Of PPE | -- | -- | 22,169 | -- |